MTOR and Hyperinsulinemia: Hyperinsulinemia with downstream IGF-1/IGF-1R signaling activates the PI3K–AKT–mTOR and MAPK pathways, supporting the survival and clonal expansion of mutated thyrocytes in the context of chronic low-grade inflammation [18].